Thursday, October 8, 2026 Never miss a recall or a rule change Get the free brief →
Inside MedSpa
FDA Recall & Compliance Alerts for Medspa Owners
Business & M&AHugel chases 1 trillion won in three yearstodaySearch DemandMedical Spa Revenue Calculator: Model Your Practice Economics5 weeks agoBusiness & M&AAbbVie takes $216M charge on Q3 deals, cuts earnings2 days agoSearch DemandWho Can Inject Botox and Filler in Florida: Scope of Practice and Licensure Requirements5 weeks agoDevices & TechDEKA and GeoMedics expand laser portfolio across India3 days agoBusiness & M&AAbbVie Files Material Event: Botox/Juvéderm Pricing Shift5 weeks agoDevices & TechBTL expands EXOMIND brain stimulation to OCD, adolescents6 days agoDevices & TechHebei Zollvan Diode Laser Clears FDA 510(k)4 weeks agoDevices & TechSkinHealth Systems launches SkinStylus in six European marketslast weekDevices & TechVIOL Scarlet Pro Wins FDA 510(k) Clearance4 weeks agoRegulatoryAllergan gets Health Canada nod for Boey, a fast-acting short-duration toxinlast weekDevices & TechECHOLASER X4 Clears FDA 510(k) for General Surgery3 weeks ago
Brightening

Hydroquinone

Prescription depigmenting agent that inhibits melanin production.

Also known as: 1,4-Benzenediol, hydroquinone monobenzoyl, same name.

What it is
Hydroquinone is a small-molecule phenolic compound that directly inhibits tyrosinase, the enzyme responsible for melanin synthesis. It is available over-the-counter at 2% concentration in most markets, and by prescription at 4% and higher.
What it does
Hydroquinone reduces melanin production by blocking tyrosinase activity and promoting melanin degradation. It lightens existing hyperpigmentation, melasma, post-inflammatory hyperpigmentation, and age spots with consistent use over 4–12 weeks. Results are visible but reversible; pigmentation typically returns within months of discontinuation.
The evidence
Strong clinical evidence supports hydroquinone's efficacy for melasma and post-inflammatory hyperpigmentation; multiple RCTs confirm 4% formulations outperform 2% and placebo. Mechanism is well-established; long safety record in dermatology, though concerns about ochronosis with prolonged use at high concentrations have emerged in some populations.
Best for
Melasma, post-inflammatory hyperpigmentation, age spots, and uneven skin tone in all skin types; particularly effective in darker skin.
Pairs well with
Tretinoin, glycolic acid, vitamin C, sunscreen (essential). Combination with retinoids and AHAs enhances penetration and efficacy.
Use cautiously with
Benzoyl peroxide (oxidizes hydroquinone and reduces efficacy). Use cautiously with other depigmenting agents (kojic acid, arbutin) without medical guidance; avoid in pregnancy without physician approval.
Cautions
May cause irritation, dryness, and contact dermatitis in sensitive skin; sun exposure can reverse results and worsen pigmentation. Prolonged use (>3–4 months) at high concentrations carries a small risk of ochronosis (blue-black discoloration), especially in darker skin tones; use under medical supervision and take periodic breaks.
General information, not medical advice. Ingredient effects vary by formulation, concentration, and skin. Patch-test new actives and consult a qualified provider before starting prescription ingredients.

Know what's coming before your patients ask for it.

New actives, device launches, and the FDA calls that change what you can offer — distilled into a two-minute brief, twice a week. Inside MedSpa Pro.

Get the free brief
Inside MedSpa · Free brief

By the time it's news, it's too late.

FDA decisions, recalls and the rules you operate under, drafted from the source documents and sent free by email.

Get the free brief The free Inside MedSpa brief · no card · unsubscribe anytime.
FDA, recalls and rule changes for practice owners Get the free brief →